Get startedLog in
    Picture of Veru logo

    VERU — Veru News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: Veru Enrolls First Patients In Phase 2B Clinical Trial Of Enobosarm And Semaglutide Combination For High Quality Weight Loss

    Picture of Veru logoVeru
    30/04/2024 14:11
    April 30 (Reuters) - Veru Inc  VERU.O :
    * VERU ENROLLS FIRST PATIENTS IN PHASE 2B CLINICAL TRIAL OF
ENOBOSARM AND SEMAGLUTIDE COMBINATION FOR HIGH QUALITY WEIGHT
LOSS
    * VERU ENROLLS FIRST PATIENTS IN PHASE 2B CLINICAL TRIAL OF
ENOBOSARM AND SEMAGLUTIDE COMBINATION FOR HIGH QUALITY WEIGHT
LOSS
    * VERU INC: TOPLINE CLINICAL DATA EXPECTED IN Q4 CALENDAR
YEAR
2024

Source text for Eikon:  ID:nGNX9pjt7N 
Further company coverage:  VERU.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Veru

    See all news